Not applicableStudy completedNCT04369703
What this trial is testing
Copeptin as a Biomarker for Central Diabetes Insipidus Development Following Pituitary Surgery
Who this might be right for
Sellar and Suprasellar MassesPituitary Tumor
Mayo Clinic 199